Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment

Annals of Clinical Biochemistry

Volumn 46, Issue 1, 2009, Pages 44-49

  Lucangioli, Silvia E ^a,b   Castaño, Gustavo ^c   Contin, Mario D ^a   Tripodi, Valeria P ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c Government of the City of Buenos Aires ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BIOLOGICAL MARKER; LITHOCHOLIC ACID; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAHEPATIC CHOLESTASIS; PREGNANCY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BILE ACIDS AND SALTS; CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; LITHOCHOLIC ACID; LIVER FUNCTION TESTS; PREGNANCY; URSODEOXYCHOLIC ACID; YOUNG ADULT;

EID: 58149520312     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2008.008130     Document Type: Article

References (28)

1. Shaw D, Frohlich J, Wittmann BA, Williams M. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 1982;142:621-5
2. Diaferia A, Nicastri P, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynecol Obstet 1996;52:133-40
3. Mazzella G, Rizzo N, Azzaroli F, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001;33:504-8
4. Walker IA, Nelson-Piercy C, Williamson C. Role of bile acid measurement in pregnancy. Ann Clin Biochem 2002;39:105-13
5. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid. Ann Hepatol 2002;1:20-8
6. Castaño G, Lucangioli S, Sookoian S, et al. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci 2006;110:459-65
7. Pascual M, Serrano M, El-Mir M, Macias R, Jimenez F, Marin J. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. Clin Sci 2002;102:587-293
8. Roda A, Gioacchini A, Manetta A, Cerre C, Montagnani M, Fini A. Bile acids: physico-chemical properties, function and activity. Ital J Gastroenterol 1995;24:327-31
9. Hoffman A, Roda A. Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res 1984;25:1477-89
10. Nomoto M, Miyata M, Shimada M, et al. ME3738 protects against lithocholic acid-induced hepatotoxicity, which is associated with enhancement of biliary bile acid and cholesterol output. Eur J Pharmacol 2007;574:192-200
11. Uppal H, Saini SP, Moschetta A, et al. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 2007;45:422-32
12. Zhang J, Huanng W, Qatanani M, Evans RM, Moore DD. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem 2004;279:49517-22
13. Saini SP, Sooda J, Xu L, et al. A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification. Mol Pharmacol 2004;65:292-300
14. Yu J, Lo JL, Huang L, et al. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 2002;277:31441-7
15. Krähenbühl S, Fischer S, Talos C, Reichen J. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria. Hepatology 1994;20:1595-601
16. Zimber A, Zusman I. Effects of secondary bile acids on the intrauterine development in the rat. Teratology 1990;42:215-24
17. Lee B, New A, Ong C. Comparative analysis of conjugated bile acids in human using high-performance liquid chromatography and capillary electrophoresis. J Chromatogr B Biomed Sci Appl 1997;704:35-42
18. Tripodi V, Lucangioli S, Scioscia S, Carducci C. Simultaneous determination of free and conjugated bile acids in serum by cyclodextrin- modified micellar electrokinetic chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2003;785:147-55
19. APGAR V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32:260-7
20. Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978;93:120-2
21. San Pedro M, Grandi C, Larguia M, Solana C. Standard of birth weight for gestational age in 55706 healthy newborns in a public maternity of Buenos Aires. Medicina (B Aires) 2001;61:15-22
22. Pradhan P. Obstetric cholestasis. J Nepal Med Assoc 2002;41:335-40
23. Mullally B, Hansen W. Intrahepatic cholestasis of pregnancy: review of the literature. Obstet Gynecol Survey 2002;57:47-52
24. Brites D, Rodrigues C, Oliveira N, Cardoso M, Graça L. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J Hepatol 1998;28:91-8
25. Lucangioli S, Carducci C, Tripodi V, Kenndler E. Retention of bile salts in micellar electrokinetic chromatography: relation of capacity factor to octanol-water partition coefficient and critical micellar concentration. J Chromatogr B Biomed Sci Appl 2001;765:113-20
26. Mazzella G, Rizzo N, Salzetta A, Iamperi R, Bovcelli L, Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet 1991;338:1594-5
27. Palma J, Reyes H, Ribalta J, et al. Ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992;15:1043-7
28. Lammert F, Ulrich-Marschall H, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and treatment. J Hepatol 2000;33:1012-21